Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,340 | -8,315 | -1,780 | -1,469 | N/A |
| Depreciation Amortization | 8,965 | 6,645 | 4,446 | 2,226 | N/A |
| Income taxes - deferred | 957 | -1,141 | -792 | -403 | N/A |
| Accounts receivable | -3,609 | 892 | -10,539 | 1,051 | N/A |
| Accounts payable and accrued liabilities | 921 | -4,741 | 3,678 | -852 | N/A |
| Other Working Capital | -15,312 | -24,797 | -14,483 | -7,160 | N/A |
| Other Operating Activity | 11,590 | 12,173 | 8,465 | 961 | 0 |
| Operating Cash Flow | $-2,828 | $-19,284 | $-11,005 | $-5,646 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,119 | 14,676 | 3,533 | 2,907 | N/A |
| PPE Investments | -4,870 | -3,636 | -2,563 | -1,136 | N/A |
| Other Investing Activity | -25 | -29 | -43 | -45 | 0 |
| Investing Cash Flow | $16,224 | $11,011 | $927 | $1,726 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,125 | 2,097 | 977 | 915 | N/A |
| Common Stock Repurchased | -15,590 | -8,916 | -4,521 | -3,918 | N/A |
| Financing Cash Flow | $-13,465 | $-6,819 | $-3,544 | $-3,003 | $N/A |
| Exchange Rate Effect | -790 | -776 | -711 | -752 | N/A |
| Beginning Cash Position | 57,189 | 57,189 | 57,189 | 57,189 | N/A |
| End Cash Position | 56,330 | 41,321 | 42,856 | 49,514 | N/A |
| Net Cash Flow | $-859 | $-15,868 | $-14,333 | $-7,675 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,828 | -19,284 | -11,005 | -5,646 | N/A |
| Capital Expenditure | -4,870 | -3,636 | -2,563 | -1,136 | N/A |
| Free Cash Flow | -7,698 | -22,920 | -13,568 | -6,782 | 0 |